Kawasaki, Japan

Kazuhiko Shirota




Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuhiko Shirota: Innovator in Isoxazole Derivatives

Introduction

Kazuhiko Shirota is an accomplished inventor based in Kawasaki, Japan, known for his significant contributions to the field of medicinal chemistry. With a strong focus on isoxazole derivatives, he has secured two patents that showcase his innovative spirit and dedication to advancing pharmaceutical research.

Latest Patents

Kazuhiko’s latest patents include groundbreaking inventions in the realm of isoxazole derivatives. The first patent features pyridylisoxazole derivatives represented by a specific formula (I), which could have potential applications in drug development. His second patent discloses pyrimidinylisoxazole derivatives, also represented by a distinct formula, further expanding the possibilities within the pharmaceutical landscape.

Career Highlights

Throughout his career, Kazuhiko Shirota has demonstrated a keen aptitude for scientific research and innovation. His work at Aska Pharmaceutical Co., Ltd. has positioned him as a key player in the pharmaceutical industry, contributing to the company’s focus on developing new therapeutic agents.

Collaborations

Kazuhiko collaborates closely with esteemed colleagues such as Koichi Hasumi and Shuji Ohta. Together, they contribute to the innovative culture at Aska Pharmaceutical Co., Ltd., driving advancements in medicinal chemistry and fostering a productive research environment.

Conclusion

Kazuhiko Shirota is a notable figure in the field of pharmaceutical innovation. With a commitment to creating new isoxazole derivatives, his contributions will undoubtedly have an impact on future therapeutic developments. His work exemplifies the importance of collaboration and innovation in advancing science and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…